Acorda Therapeutics, Inc.
ACORQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.36M | 29.98M | 32.47M | 25.27M | 30.26M |
| Total Receivables | 9.19M | 17.30M | 11.98M | 13.39M | 9.19M |
| Inventory | 14.12M | 16.16M | 17.94M | 14.80M | 13.47M |
| Prepaid Expenses | 12.62M | 5.21M | 5.04M | 5.48M | 4.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.17M | 6.15M | 6.30M | 5.98M | 11.06M |
| Total Current Assets | 48.45M | 74.79M | 73.73M | 64.91M | 68.09M |
|
|
|||||
| Total Current Assets | 48.45M | 74.79M | 73.73M | 64.91M | 68.09M |
| Net Property, Plant & Equipment | 5.83M | 6.30M | 6.71M | 6.93M | 7.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 22.34M | 22.99M | 282.01M | 289.70M | 297.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.95M | 4.44M | 3.90M | 3.15M | 2.01M |
| Total Assets | 81.58M | 108.53M | 366.34M | 364.70M | 374.91M |
|
|
|||||
| Total Accounts Payable | 9.93M | 13.37M | 12.33M | 3.18M | 2.85M |
| Total Accrued Expenses | 17.67M | 24.31M | 29.34M | 21.82M | 27.02M |
| Short-term Debt | 191.47M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.60M | 187.73M | 1.58M | 1.57M | 1.56M |
| Total Finance Division Other Current Liabilities | 3.27M | 2.36M | 3.04M | 3.82M | 3.31M |
| Total Other Current Liabilities | 3.27M | 2.36M | 3.04M | 3.82M | 3.31M |
| Total Current Liabilities | 223.94M | 227.77M | 46.29M | 30.39M | 34.74M |
|
|
|||||
| Total Current Liabilities | 223.94M | 227.77M | 46.29M | 30.39M | 34.74M |
| Long-Term Debt | -- | -- | 181.04M | 176.16M | 171.50M |
| Short-term Debt | 191.47M | -- | -- | -- | -- |
| Capital Leases | 2.85M | 3.17M | 3.47M | 3.76M | 4.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 40.56M | 35.54M | 76.58M | 86.51M | 87.66M |
| Total Liabilities | 267.35M | 266.48M | 307.39M | 296.83M | 297.95M |
|
|
|||||
| Common Stock & APIC | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B |
| Retained Earnings | -1.22B | -1.19B | -971.37M | -962.48M | -953.10M |
| Treasury Stock & Other | 237.00K | 787.00K | 79.00K | 242.00K | 81.00K |
| Total Common Equity | -185.77M | -157.96M | 58.96M | 67.87M | 76.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -185.77M | -157.96M | 58.96M | 67.87M | 76.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -185.77M | -157.96M | 58.96M | 67.87M | 76.96M |
|
|
|||||
